Project Grant R01MH140465
- The University of Washington was awarded a $985,308 Project Grant from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) to advance pharmacy-based delivery of primary sexually transmitted infection (STI) and HIV prevention for cisgender women in Kenya. The funding supports research to evaluate strategies for addressing STIs and promoting HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) uptake...
- This Project Grant award from the National Institute of Nursing Research (NINR) under the Nursing Research federal grant program (CFDA 93.361) supports research to investigate the mechanisms of action for a mobile SMS-based pre-exposure prophylaxis (PrEP) adherence intervention in Kenya. The $205,948 award to the University of Washington will be used to analyze data from the parent MWACH PrEP study, which is testing the impact of an interactive SMS platform on PrEP adherence and maintenance...
- This federal Project Grant award of $234,292 from the National Institutes of Health's Fogarty International Center (CFDA 93.989 - International Research and Research Training) aims to develop and pilot test a multilevel, community-based intervention to reduce pre-exposure prophylaxis (PrEP) stigma and increase PrEP uptake and continuation among adolescent girls and young women (AGYW) ages 15-24 in Western Kenya. The key products and services to be delivered under this 3-year award include: 1)...
- The University of South Florida (USF) received a $389,527 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) to conduct a study examining strategies and contextual factors that optimize the delivery of pre-exposure prophylaxis (PrEP) for HIV prevention in Kenya. The key products and services to be delivered through this two-year project include: Identifying implementation strategies and contextual factors that...
- This federal Project Grant award titled "STREAMLINING TELEHEALTH FOR EXPANDED PREP UTILIZATION THROUGH COMMUNITY PARTNERSHIPS (STEP-UP)" is funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The $744,279 award, effective from September 18, 2025 to September 17, 2028, supports the development and evaluation of an innovative model that positions community-based organizations (CBOs) as hubs for delivering pre-exposure...
- This federal Project Grant award for $657,907 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support a 5-year longitudinal analysis to understand the impact of expanding pharmacists' scope of practice on the uptake and retention of pre-exposure prophylaxis (PrEP) for HIV prevention. The project aims to integrate multiple data sources, including policy, census, survey, and medical claims data, to...
- This Project Grant award of $769,471 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports the "HIV Enhanced Access Testing in Emergency Department Program Using a Systems Analysis and Improvement Approach (HEATED-SAIA) Cluster Randomized Trial". The program aims to enhance delivery of HIV testing services (HTS) in emergency departments (EDs) in Kenya, targeting hard-to-reach populations like men, adolescents,...
- This $631,589 Project Grant award from the National Heart Lung and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837) will examine the implementation, effectiveness, and cost-effectiveness of two strategies for integrating a community health worker-facilitated hypertension telehealth intervention into primary health centers in Kenya. The goal is to address multi-level barriers to effective hypertension treatment and management. The two implementation approaches are:...
- This Project Grant award of $962,973.00 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to develop and evaluate a comprehensive curriculum on HIV prevention and implementation science for pharmacy schools in the southern United States. The project, titled "Pharmacists for Prevention (P4P): Harnessing the Role of Pharmacists in Ending the HIV Epidemic through Collaboration with Pharmacy Schools," will be...
- This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $3,554,273 to the Fred Hutchinson Cancer Center in Seattle, WA to assess the impact of oral pre-exposure prophylaxis (PrEP) on the pharmacokinetics of monoclonal antibodies and vaccine-induced antibodies among women vulnerable to HIV-1. The key objectives of this 4-year award are to: 1) Determine whether oral...
The Department of Health and Human Services National Institutes of Health (NIH) awarded a $250,000 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Fred Hutchinson Cancer Center, also known as the Seattle Cancer Care Alliance, to conduct a hybrid effectiveness-implementation cluster-randomized controlled trial across 20 pharmacies in Kenya. The goal of the project is to leverage telehealth to optimize the delivery of pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) for HIV prevention. Specifically, the study will 1:1 randomize the pharmacies to either receive telehealth support from a remote nurse or standard delivery by the pharmacy providers alone, with the primary outcomes being PrEP/PEP initiations and continuation at 6 months. This research aims to address implementation challenges and improve clinical outcomes in expanding access to these highly effective HIV prevention interventions in Kenya. The project period runs from September 12, 2025 to June 30, 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $250.0k | 9/12/25 |